About this data
What it is
When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
Who files it
The insider, usually through the company, within two business days of the trade.
How current
We collect new filings throughout the day on SEC business days.
Worth knowing
Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.

All of this comes from public filings.

Open-market trades per day, last 30 days

05001,000Oct 17 · Purchases: 0Oct 17 · Sales: 0Oct 17Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 21Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 25Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 29Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 2Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 6Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 10Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 14Nov 15 · Purchases: 0Nov 15 · Sales: 0
05001,000Oct 17 · Purchases: 0Oct 17 · Sales: 0Oct 17Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 21Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 25Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 29Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 2Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 6Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 10Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 14Nov 15 · Purchases: 0Nov 15 · Sales: 0

Purchases Sales

By trade date. Insiders have two business days to file, so the most recent days fill in later.

Latest open-market insider trades

Reset

Showing: ticker LUNG

Latest open-market insider trades
TradedInsiderCompanyTypeSharesPriceValueFiling
Sep 1, 2026Srikanth Radhakrishnan
Chief Science & Techn. Officer
LUNG
Pulmonx Corporation
Sale5,863$2.26$13.3K SaleForm 4 ↗
Sep 1, 2026Srikanth Radhakrishnan
Chief Science & Techn. Officer
LUNG
Pulmonx Corporation
Sale3,618$2.26$8,177 SaleForm 4 ↗
Sep 1, 2026Srikanth Radhakrishnan
Chief Science & Techn. Officer
LUNG
Pulmonx Corporation
Sale2,121$2.26$4,793 SaleForm 4 ↗
Sep 1, 2026Srikanth Radhakrishnan
Chief Science & Techn. Officer
LUNG
Pulmonx Corporation
Sale2,643$2.26$5,973 SaleForm 4 ↗
Sep 1, 2026Glendon E. French III
President and CEO, Director
LUNG
Pulmonx Corporation
Sale37,784$2.26$85.4K SaleForm 4 ↗
Sep 1, 2026Glendon E. French III
President and CEO, Director
LUNG
Pulmonx Corporation
Sale4,098$2.26$9,261 SaleForm 4 ↗
Sep 1, 2026Geoffrey Beran Rose
Chief Commercial Officer
LUNG
Pulmonx Corporation
Sale1,746$2.26$3,946 SaleForm 4 ↗
Sep 1, 2026Geoffrey Beran Rose
Chief Commercial Officer
LUNG
Pulmonx Corporation
Sale1,530$2.26$3,458 SaleForm 4 ↗
Sep 1, 2026Geoffrey Beran Rose
Chief Commercial Officer
LUNG
Pulmonx Corporation
Sale2,390$2.26$5,401 SaleForm 4 ↗
Sep 1, 2026Geoffrey Beran Rose
Chief Commercial Officer
LUNG
Pulmonx Corporation
Sale2,213$2.26$5,001 SaleForm 4 ↗
Sep 1, 2026David Aaron Lehman
General Counsel
LUNG
Pulmonx Corporation
Sale4,827$2.26$10.9K SaleForm 4 ↗
Sep 1, 2026David Aaron Lehman
General Counsel
LUNG
Pulmonx Corporation
Sale3,476$2.26$7,856 SaleForm 4 ↗
Sep 1, 2026David Aaron Lehman
General Counsel
LUNG
Pulmonx Corporation
Sale2,224$2.26$5,026 SaleForm 4 ↗
Sep 1, 2026David Aaron Lehman
General Counsel
LUNG
Pulmonx Corporation
Sale3,807$2.26$8,604 SaleForm 4 ↗
Jun 2, 2026Glendon E. French III
President and CEO, Director
LUNG
Pulmonx Corporation
Sale13,511$1.57$21.2K SaleForm 4 ↗
Jun 1, 2026Srikanth Radhakrishnan
Chief Science &Techn. Officer
LUNG
Pulmonx Corporation
Sale5,969$1.54$9,192 SaleForm 4 ↗
Jun 1, 2026Srikanth Radhakrishnan
Chief Science &Techn. Officer
LUNG
Pulmonx Corporation
Sale3,684$1.54$5,673 SaleForm 4 ↗
Jun 1, 2026Srikanth Radhakrishnan
Chief Science &Techn. Officer
LUNG
Pulmonx Corporation
Sale2,153$1.54$3,316 SaleForm 4 ↗
Jun 1, 2026Srikanth Radhakrishnan
Chief Science &Techn. Officer
LUNG
Pulmonx Corporation
Sale2,691$1.54$4,144 SaleForm 4 ↗
Jun 1, 2026Glendon E. French III
President and CEO, Director
LUNG
Pulmonx Corporation
Sale38,467$1.54$59.2K SaleForm 4 ↗
Jun 1, 2026Glendon E. French III
President and CEO, Director
LUNG
Pulmonx Corporation
Sale4,171$1.54$6,423 SaleForm 4 ↗
Jun 1, 2026Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
LUNG
Pulmonx Corporation
Sale2,254$1.54$3,471 SaleForm 4 ↗
Jun 1, 2026Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
LUNG
Pulmonx Corporation
Sale2,434$1.54$3,748 SaleForm 4 ↗
Jun 1, 2026Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
LUNG
Pulmonx Corporation
Sale1,557$1.54$2,398 SaleForm 4 ↗
Jun 1, 2026Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
LUNG
Pulmonx Corporation
Sale1,778$1.54$2,738 SaleForm 4 ↗
Jun 1, 2026David Aaron Lehman
GENERAL COUNSEL
LUNG
Pulmonx Corporation
Sale4,915$1.54$7,569 SaleForm 4 ↗
Jun 1, 2026David Aaron Lehman
GENERAL COUNSEL
LUNG
Pulmonx Corporation
Sale3,539$1.54$5,450 SaleForm 4 ↗
Jun 1, 2026David Aaron Lehman
GENERAL COUNSEL
LUNG
Pulmonx Corporation
Sale2,264$1.54$3,487 SaleForm 4 ↗
Jun 1, 2026David Aaron Lehman
GENERAL COUNSEL
LUNG
Pulmonx Corporation
Sale3,876$1.54$5,969 SaleForm 4 ↗
Mar 2, 2026Srikanth Radhakrishnan
Chief Science &Techn. Officer
LUNG
Pulmonx Corporation
Sale4,198$1.43$6,003 SaleForm 4 ↗
Mar 2, 2026Srikanth Radhakrishnan
Chief Science &Techn. Officer
LUNG
Pulmonx Corporation
Sale2,461$1.43$3,519 SaleForm 4 ↗
Mar 2, 2026Srikanth Radhakrishnan
Chief Science &Techn. Officer
LUNG
Pulmonx Corporation
Sale3,068$1.43$4,387 SaleForm 4 ↗
Mar 2, 2026Srikanth Radhakrishnan
Chief Science &Techn. Officer
LUNG
Pulmonx Corporation
Sale756$1.43$1,081 SaleForm 4 ↗
Mar 2, 2026Glendon E. French III
President and CEO, Director
LUNG
Pulmonx Corporation
Sale58,368$1.43$83.5K SaleForm 4 ↗
Mar 2, 2026Glendon E. French III
President and CEO, Director
LUNG
Pulmonx Corporation
Sale6,737$1.43$9,634 SaleForm 4 ↗
Mar 2, 2026Glendon E. French III
President and CEO, Director
LUNG
Pulmonx Corporation
Sale2,708$1.43$3,872 SaleForm 4 ↗
Mar 2, 2026Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
LUNG
Pulmonx Corporation
Sale2,911$1.43$4,163 SaleForm 4 ↗
Mar 2, 2026Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
LUNG
Pulmonx Corporation
Sale1,861$1.43$2,661 SaleForm 4 ↗
Mar 2, 2026Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
LUNG
Pulmonx Corporation
Sale2,125$1.43$3,039 SaleForm 4 ↗
Mar 2, 2026Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
LUNG
Pulmonx Corporation
Sale835$1.43$1,194 SaleForm 4 ↗
Mar 2, 2026David Aaron Lehman
GENERAL COUNSEL
LUNG
Pulmonx Corporation
Sale4,051$1.43$5,793 SaleForm 4 ↗
Mar 2, 2026David Aaron Lehman
GENERAL COUNSEL
LUNG
Pulmonx Corporation
Sale2,590$1.43$3,704 SaleForm 4 ↗
Mar 2, 2026David Aaron Lehman
GENERAL COUNSEL
LUNG
Pulmonx Corporation
Sale4,433$1.43$6,339 SaleForm 4 ↗
Mar 2, 2026David Aaron Lehman
GENERAL COUNSEL
LUNG
Pulmonx Corporation
Sale1,163$1.43$1,663 SaleForm 4 ↗
Dec 8, 2025Daniel P. Florin
Director
LUNG
Pulmonx Corporation
Sale23,321$1.99$46.4K SaleForm 4 ↗
Dec 1, 2025Glendon E. French III
President and CEO, Director
LUNG
Pulmonx Corporation
Sale6,281$1.57$9,861 SaleForm 4 ↗
Dec 1, 2025Glendon E. French III
President and CEO, Director
LUNG
Pulmonx Corporation
Sale2,524$1.57$3,963 SaleForm 4 ↗
Dec 1, 2025Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
LUNG
Pulmonx Corporation
Sale2,379$1.57$3,735 SaleForm 4 ↗
Dec 1, 2025Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
LUNG
Pulmonx Corporation
Sale1,522$1.57$2,390 SaleForm 4 ↗
Dec 1, 2025Geoffrey Beran Rose
CHIEF COMMERCIAL OFFICER
LUNG
Pulmonx Corporation
Sale1,738$1.57$2,729 SaleForm 4 ↗

The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:16 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances